• Menu
  • Skip to right header navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Before Header

 TudorRose Consulting is now part of Adjutor Healthcare.   Same team.   More Expert Services.    Meet Adjutor

This is the official © Adjutor Healthcare Logo. It is subject to copyright and may not be used in any way or form without the express permission of Adjutor Healthcare Pty Ltd.

A global provider of development and commercialisation services to the pharmaceutical, biotechnology and medical device industries.

  • What We Do
  • Why Choose Us
  • Who We Are
  • Helpers Blog
  • Join Our Team
  • Contact Us
  • What We Do
  • Why Choose Us
  • Who We Are
  • Helpers Blog
  • Join Our Team
  • Contact Us

Therapeutic Product Commercialization

March 11, 2020 //  by Adjutor Healthcare

We may have a global market but do we really consider options outside of USA and EU when developing our Therapeutic Product Commercialization strategy?

Therapeutic Product Commercialization - We may have a global market but do we really consider options outside of USA and EU enough when developing our strategy?

The USA, EU/UK are large markets with clear regulatory requirements, so they are often first targets for therapeutic product commercialization, either for medicines or medical devices. 

A New Perspective

But what if… you could launch in another country sooner and begin a (smaller) revenue stream earlier?

How would that boost your share price, cashflow, team morale and investor confidence when partnering or licensing? 

Commercialization planning needs to be a whole of world exercise, including all relevant key elements such as the stage of your CMC development program, early clinical trial results and likelihood of reimbursement in the target markets.

Going single-mindedly for a traditional market with the highest $ returns as the first target may not be the best option overall, particularly if you have an early exit strategy.

Countries such as Australia have a well recognised and highly respected regulatory agency in the Therapeutic Goods Administration (TGA). The TGA is also involved in multiple work sharing and mutual recognition arrangements that may facilitate your next approval in a larger market.

An early approval will also help to validate your development program.

Share this post:

TwitterFacebookLinkedInEmail

Category: Adjutor HealthcareTag: Commercialization, Global Markets, Medical Devices, Medicines, Strategy, Therapeutic Goods

No time to waste?

Contact us today for an initial consultation and learn
how we can add value to your business.

CONTACT US TODAY

You May Also Be Interested In…

Despite the postponement of the EU Medical Devices Regulation implementation to May 2021 appearing to offer breathing room, it has actually shortened the transition time for many manufacturers!

EU MDR: Are ROW Device Sponsors Ready for the Ripple Effect?

Image depicts the Australian government 2020 budget cash splash on high tech and science recovery.

Australian Government Cash Splash on High Tech Recovery

TGA's new Product Information (PI) Form: If you need support to meet the 31 December 2020 deadline, we’re here to help.

The Pointy End of the PI Reformatting Transition Period

Therapeutic Product Commercialization - We may have a global market but do we really consider options outside of USA and EU enough when developing our strategy?

Therapeutic Product Commercialization

Medsafe NZ has been working on a new therapeutic products regulatory regime to replace and modernise the regulatory arrangements for medicines.

MEDSAFE NZ Moves Ahead in 2020

Adjutor Healthcare announces launch of Adjutor Healthcare New Zealand Limited consulting and sponsorship entity for medicines and medical devices.

Launch of Adjutor Healthcare (NZ) Limited

The Federal Court imposes $10 million penalty for the alleged Peptide Clinics advertising breaches. Peptide Clinics Pty Ltd was liquidated earlier this year.

Consumer Insecurity / Vanity Targeted by TGA – Massive Fines

Australian Employment Regulations - Compliance Alert Banner.

Australian Employment Regulations

The TGA has released new guidelines for Advertizing Therapeutic Goods in 2019. Image depicts Fireworks over Sydney Harbour Bridge, New Years Eve January 2019

Advertizing Therapeutic Goods in Australia

Footer

Company Profile

Adjutor Healthcare Pty Ltd is part of a worldwide network that spans 90 countries.

We provide seamless services across development and commercialization of your products internationally.

Read More

Contact Us

Adjutor Healthcare Pty Ltd

  +61 418 314 763

  rosalie.cull@adjutor.com.au

  • Email
  • LinkedIn
  • Phone

Email Newsletter

Sign up to receive the latest industry news updates!

© 2021 Adjutor Healthcare · All Rights Reserved · Web Services by Kracked Kreative
We use cookies to ensure that you have the best experience on our website.OKPrivacy policy